Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities
International Journal of Molecular Sciences · 24.10.2023 · 24 (21) · 15500
DOI: 10.3390/ijms242115500 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.10.2023. Verfasst von Ana Bogut und 12 weiteren Autor:innen. Beteiligte Einrichtung: City Medical Emergency Department, 11000 Belgrade, Serbia. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Galectin 1, Pancreatic Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia, the Faculty of Medical Sciences at the University of Kragujevac, Serbia, the Ministry of Science, Technological Development, and Innovation of the Republic of Serbia.
Abstract (Originalsprache)
Pancreatic Ductal Adenocarcinoma (PDAC) remains one of the most challenging malignancies to treat, with a complex interplay of molecular pathways contributing to its aggressive nature. Galectin-1 (Gal-1), a member of the galectin family, has emerged as a pivotal player in the PDAC microenvironment, influencing various aspects from tumor growth and angiogenesis to immune modulation. This review provides a comprehensive overview of the multifaceted role of Galectin-1 in PDAC. We delve into its contributions to tumor stroma remodeling, angiogenesis, metabolic reprogramming, and potential implications for therapeutic interventions. The challenges associated with targeting Gal-1 are discussed, given its pleiotropic functions and complexities in different cellular conditions. Additionally, the promising prospects of Gal-1 inhibition, including the utilization of nanotechnology and theranostics, are highlighted. By integrating recent findings and shedding light on the intricacies of Gal-1’s involvement in PDAC, this review aims to provide insights that could guide future research and therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- City Medical Emergency Department, 11000 Belgrade, Serbia.
- Department of Surgery, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.
- Department of General Surgery, University Clinical Center Kragujevac, 34000 Kragujevac, Serbia.
- Department of Internal Medicine, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.
- Department of Pathology, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.
- Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.
ORCID-Profile: Bojan Stojanovic, Aleksandar Lazovic, Ivan Jovanovic
Förderung
- Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia
- the Faculty of Medical Sciences at the University of Kragujevac, Serbia
- the Ministry of Science, Technological Development, and Innovation of the Republic of Serbia
Zitieren
APA
Bogut, A., Stojanovic, B., Jovanovic, M., Dimitrijevic Stojanovic, M., Gajovic, N., Stojanovic, B. S., Balovic, G., Jovanovic, M., Lazovic, A., Mirovic, M., Jurisevic, M., Jovanovic, I., & Mladenovic, V. (2023). Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities. International Journal of Molecular Sciences, 24(21), 15500. https://doi.org/10.3390/ijms242115500
Vancouver
Bogut A, Stojanovic B, Jovanovic M, Dimitrijevic Stojanovic M, Gajovic N, Stojanovic BS, et al. Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities. International Journal of Molecular Sciences. 2023;24(21):15500. doi:10.3390/ijms242115500
BibTeX
@article{Bogut2023,
author = {Bogut, Ana and Stojanovic, Bojan and Jovanovic, Marina and Dimitrijevic Stojanovic, Milica and Gajovic, Nevena and Stojanovic, Bojana S and Balovic, Goran and Jovanovic, Milan and Lazovic, Aleksandar and Mirovic, Milos and Jurisevic, Milena and Jovanovic, Ivan and Mladenovic, Violeta},
title = {Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {21},
pages = {15500},
doi = {10.3390/ijms242115500}
}
EUVIMED